UY32037A - Daa-piridina - Google Patents
Daa-piridinaInfo
- Publication number
- UY32037A UY32037A UY0001032037A UY32037A UY32037A UY 32037 A UY32037 A UY 32037A UY 0001032037 A UY0001032037 A UY 0001032037A UY 32037 A UY32037 A UY 32037A UY 32037 A UY32037 A UY 32037A
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- daa
- pyridine
- compositions
- elements
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nuclear Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Compuestos nuevos adecuados para marcar o ya marcados con 18F, con métodos para preparar tales compuestos, con composiciones que comprenden dichos compuestos, con conjuntos de elementos que comprenden dichos compuestos, composiciones o conjunto de elementos en terapia y para diagnóstico por imágenes mediante tomografía de emisión de positrones (PET).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08161903 | 2008-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32037A true UY32037A (es) | 2010-03-26 |
Family
ID=41198601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032037A UY32037A (es) | 2008-08-06 | 2009-08-05 | Daa-piridina |
Country Status (24)
Country | Link |
---|---|
US (1) | US20110200535A1 (es) |
EP (1) | EP2321279B1 (es) |
JP (1) | JP2011529929A (es) |
KR (1) | KR20110041559A (es) |
CN (1) | CN102112448B (es) |
AR (1) | AR073263A1 (es) |
AU (1) | AU2009278279B2 (es) |
BR (1) | BRPI0917099A2 (es) |
CA (1) | CA2733105A1 (es) |
CL (1) | CL2011000237A1 (es) |
CO (1) | CO6351715A2 (es) |
CR (1) | CR20110064A (es) |
DO (1) | DOP2011000046A (es) |
EA (1) | EA018650B1 (es) |
EC (1) | ECSP11010808A (es) |
IL (1) | IL210597A0 (es) |
MX (1) | MX2011001406A (es) |
NZ (1) | NZ590923A (es) |
PE (1) | PE20110226A1 (es) |
SV (1) | SV2011003830A (es) |
TW (1) | TW201010734A (es) |
UY (1) | UY32037A (es) |
WO (2) | WO2010015340A1 (es) |
ZA (1) | ZA201101700B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2474525B1 (en) | 2006-12-26 | 2020-04-15 | Lantheus Medical Imaging, Inc. | Ligands for imaging cardiac innervation |
WO2010015340A1 (en) * | 2008-08-06 | 2010-02-11 | Bayer Schering Pharma Aktiengesellschaft | Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
GB0904715D0 (en) * | 2009-03-19 | 2009-05-06 | Ge Healthcare Ltd | Aryloxyanilide derivataives |
WO2011110488A1 (en) * | 2010-03-09 | 2011-09-15 | Bayer Pharma Aktiengesellschaft | A novel pet imaging agent of amyloid plaques and its precursor |
NZ604233A (en) | 2010-05-11 | 2014-10-31 | Lantheus Medical Imaging Inc | Compositions, methods and systems for the synthesis and use of imaging agents |
JP6022442B2 (ja) | 2010-05-14 | 2016-11-09 | ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド | 男性用避妊組成物および使用方法 |
MX354217B (es) | 2010-05-14 | 2018-02-19 | Dana Farber Cancer Inst Inc | Composiciones y metodos para el tratamiento de leucemia. |
AU2011252808B2 (en) | 2010-05-14 | 2015-05-14 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for treating neoplasia, inflammatory disease and other disorders |
ES2731471T3 (es) | 2011-09-09 | 2019-11-15 | Lantheus Medical Imaging Inc | Composiciones, métodos y sistemas para la síntesis y el uso de agentes de obtención de imágenes |
BR112016001457A2 (pt) | 2013-07-25 | 2017-08-29 | Dana Farber Cancer Inst Inc | Inibidores de fatores de transcrição e usos dos mesmos |
US11446309B2 (en) | 2013-11-08 | 2022-09-20 | Dana-Farber Cancer Institute, Inc. | Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors |
KR20160115953A (ko) | 2014-01-31 | 2016-10-06 | 다나-파버 캔서 인스티튜트 인크. | 디아미노피리미딘 벤젠술폰 유도체 및 그의 용도 |
WO2015117087A1 (en) | 2014-01-31 | 2015-08-06 | Dana-Farber Cancer Institute, Inc. | Uses of diazepane derivatives |
RU2722179C2 (ru) | 2014-02-28 | 2020-05-28 | Тэнша Терапеутикс, Инк. | Лечение состояний, ассоциированных с гиперинсулинемией |
MX2017001756A (es) | 2014-08-08 | 2017-05-30 | Dana Farber Cancer Inst Inc | Derivados de diazepano y sus usos. |
MX2017001757A (es) | 2014-08-08 | 2017-05-30 | Dana Farber Cancer Inst Inc | Derivados de dihidropteridinona y sus usos. |
EP3212654B1 (en) | 2014-10-27 | 2020-04-08 | Tensha Therapeutics, Inc. | Bromodomain inhibitors |
AU2016276963C1 (en) | 2015-06-12 | 2021-08-05 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
UA123946C2 (uk) | 2015-09-11 | 2021-06-30 | Дана-Фарбер Кенсер Інстітьют, Інк. | Ацетамідтієнотриазолодіазепіни й шляхи їх застосування |
RU2750164C2 (ru) | 2015-09-11 | 2021-06-22 | Дана-Фарбер Кэнсер Инститьют, Инк. | Цианотиенотриазолодиазепины и пути их применения |
WO2017091673A2 (en) | 2015-11-25 | 2017-06-01 | Dana-Farber Cancer Institute, Inc. | Bivalent bromodomain inhibtors and uses thereof |
CN105541931B (zh) * | 2016-01-07 | 2018-08-17 | 江西师范大学 | 一种氟代糖苷衍生物及其制备方法 |
EA202091323A1 (ru) * | 2017-12-01 | 2020-10-09 | Юсб Байофарма Срл | Визуализирующие средства |
CN111039853B (zh) * | 2019-12-26 | 2023-02-14 | 安徽大学 | 一种可用于光声成像和光热治疗的铁配合物及其制备方法和用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2186186T3 (es) * | 1997-08-04 | 2003-05-01 | Taisho Pharmaceutical Co Ltd | Derivados ariloxianilina. |
JP2000001476A (ja) * | 1998-06-15 | 2000-01-07 | Taisho Pharmaceut Co Ltd | アリールオキシ含窒素アリールアミン誘導体 |
JP2004231647A (ja) * | 2003-01-10 | 2004-08-19 | Natl Inst Of Radiological Sciences | フェニルオキシアニリン誘導体 |
US6870069B2 (en) * | 2003-01-10 | 2005-03-22 | National Institute Of Radiological Sciences | Phenyloxyaniline derivatives |
GB0329716D0 (en) * | 2003-12-23 | 2004-01-28 | Amersham Plc | Radical trap |
GB0407952D0 (en) * | 2004-04-08 | 2004-05-12 | Amersham Plc | Fluoridation method |
US8644910B2 (en) * | 2005-07-19 | 2014-02-04 | Biosensors International Group, Ltd. | Imaging protocols |
DE102005055524B4 (de) * | 2005-11-22 | 2013-02-07 | BEGO Bremer Goldschlägerei Wilh. Herbst GmbH & Co. KG | Verfahren, Vorrichtung und System zur Herstellung eines keramischen Formkörpers |
US20080293969A1 (en) * | 2005-11-22 | 2008-11-27 | Ge Healthcare Limited | 18F-Labeled Daa Analogues and Method of Labeling These Analogues as Positron Emission Tomography (Pet) Tracers For Imaging Peripheral Benzodiazepine Receptors |
GB0525949D0 (en) * | 2005-12-21 | 2006-02-01 | Hammersmith Imanet Ltd | Pet radiotracers |
MX2008016344A (es) * | 2006-06-21 | 2009-02-12 | Ge Healthcare Ltd | Productos radiofarmaceuticos. |
WO2010015340A1 (en) * | 2008-08-06 | 2010-02-11 | Bayer Schering Pharma Aktiengesellschaft | Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
-
2009
- 2009-07-25 WO PCT/EP2009/005399 patent/WO2010015340A1/en active Application Filing
- 2009-08-03 TW TW098126076A patent/TW201010734A/zh unknown
- 2009-08-05 WO PCT/EP2009/005651 patent/WO2010015387A1/en active Application Filing
- 2009-08-05 CN CN200980130507.6A patent/CN102112448B/zh not_active Expired - Fee Related
- 2009-08-05 NZ NZ590923A patent/NZ590923A/xx not_active IP Right Cessation
- 2009-08-05 MX MX2011001406A patent/MX2011001406A/es not_active Application Discontinuation
- 2009-08-05 UY UY0001032037A patent/UY32037A/es not_active Application Discontinuation
- 2009-08-05 US US13/057,215 patent/US20110200535A1/en not_active Abandoned
- 2009-08-05 EA EA201100301A patent/EA018650B1/ru not_active IP Right Cessation
- 2009-08-05 BR BRPI0917099A patent/BRPI0917099A2/pt not_active IP Right Cessation
- 2009-08-05 JP JP2011521474A patent/JP2011529929A/ja active Pending
- 2009-08-05 KR KR1020117005160A patent/KR20110041559A/ko not_active Application Discontinuation
- 2009-08-05 CA CA2733105A patent/CA2733105A1/en not_active Abandoned
- 2009-08-05 AU AU2009278279A patent/AU2009278279B2/en not_active Ceased
- 2009-08-05 AR ARP090102997A patent/AR073263A1/es not_active Application Discontinuation
- 2009-08-05 EP EP09777654.6A patent/EP2321279B1/en not_active Not-in-force
- 2009-08-05 PE PE2011000123A patent/PE20110226A1/es not_active Application Discontinuation
-
2011
- 2011-01-12 IL IL210597A patent/IL210597A0/en unknown
- 2011-02-04 SV SV2011003830A patent/SV2011003830A/es not_active Application Discontinuation
- 2011-02-04 EC EC2011010808A patent/ECSP11010808A/es unknown
- 2011-02-04 CO CO11013225A patent/CO6351715A2/es not_active Application Discontinuation
- 2011-02-04 CL CL2011000237A patent/CL2011000237A1/es unknown
- 2011-02-04 DO DO2011000046A patent/DOP2011000046A/es unknown
- 2011-02-04 CR CR20110064A patent/CR20110064A/es unknown
- 2011-03-04 ZA ZA2011/01700A patent/ZA201101700B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201101700B (en) | 2014-08-27 |
MX2011001406A (es) | 2011-03-21 |
EP2321279B1 (en) | 2014-07-02 |
AU2009278279B2 (en) | 2014-04-17 |
US20110200535A1 (en) | 2011-08-18 |
IL210597A0 (en) | 2011-03-31 |
JP2011529929A (ja) | 2011-12-15 |
CA2733105A1 (en) | 2010-02-11 |
CO6351715A2 (es) | 2011-12-20 |
DOP2011000046A (es) | 2011-02-28 |
CN102112448B (zh) | 2014-08-06 |
EP2321279A1 (en) | 2011-05-18 |
CN102112448A (zh) | 2011-06-29 |
WO2010015387A1 (en) | 2010-02-11 |
TW201010734A (en) | 2010-03-16 |
CL2011000237A1 (es) | 2011-07-29 |
NZ590923A (en) | 2012-12-21 |
EA018650B1 (ru) | 2013-09-30 |
ECSP11010808A (es) | 2011-03-31 |
AR073263A1 (es) | 2010-10-28 |
CR20110064A (es) | 2011-03-30 |
WO2010015340A1 (en) | 2010-02-11 |
KR20110041559A (ko) | 2011-04-21 |
SV2011003830A (es) | 2011-05-20 |
BRPI0917099A2 (pt) | 2016-02-16 |
EA201100301A1 (ru) | 2011-12-30 |
PE20110226A1 (es) | 2011-04-01 |
AU2009278279A1 (en) | 2010-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32037A (es) | Daa-piridina | |
CL2012002189A1 (es) | Compuestos derivados de pirrolidina-2-carboxamidas sustituidas; inhibidores de la interaccion mdm2-p53; composicion farmaceutica; y su uso para el tratamiento del cancer, en particular de tumores solidos. | |
MX2013012793A (es) | Aminoacidos radiomarcados para imagen de diagnostico. | |
CR20110466A (es) | Anticuerpos biespecíficos anti-erbb-3/anti-c-met | |
CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
NI201100082A (es) | Compuestos de isoindolina para uso en el tratamiento de cáncer. | |
BR112012032008A2 (pt) | anticorpos s100a4 e usos terapêuticos do mesmo | |
BR112012016129A2 (pt) | composto, composição, e, métodos para inibir a atividade de c-met, e para tratar câncer | |
CO6551740A2 (es) | Derivados pirazólicos como moduladores de los canales de calcio activados por la liberación de calcio | |
BRPI0715396B8 (pt) | método de produção de uma composição para vacina | |
NZ606466A (en) | Peptide radiotracer compositions | |
UY30595A1 (es) | Métodos de marcacion con fluor radioactivo | |
BR112015015368A2 (pt) | composições de absorventes de dejetos de animais revestidas debaixa densidade | |
WO2009052970A3 (en) | Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors | |
BR112012022337A2 (pt) | composição e respectivos método de preparação e uso de quantidade eficaz | |
UY33274A (es) | Proteínas de unión a basigina | |
BR112012021579A2 (pt) | traçador de tomografia por emissão de pósitron, composto precursor, método para preparar o composto precursor, cassete, composição radiofarmacêutica, método de formação de imagem por tomografia por emissão de pósitron, e, método para diagnose de uma condição. | |
BR112012014621A2 (pt) | processo para a preparação de compostos de quelato | |
AU2010332841A8 (en) | Prostate specific membrane antigen inhibitors | |
BR112012027316A2 (pt) | métodos para obter um traçador de tomografia por emissão de pósitron e para a preparação do composto, e, cassete | |
CL2009001342A1 (es) | Pregn-4-en-21,17-carbolactonas sustituidas en el anillo c; preparados farmaceuticos que lo contienen; compuesto 11 alfa-hidroxi-15 beta, 16 beta-metilen-androst-4-en-3,17-diona; procedimiento para preparar dicho compuesto que comprende el uso de microorganismos. | |
MX2012012479A (es) | Metodos, composiciones y accesorios para proporcionar un tratamiento terapeutico. | |
BR112012019920A2 (pt) | derivados de piridazina úteis como agonístas de canabinoide-2. | |
WO2012072736A3 (en) | Radioconjugation method | |
MX340487B (es) | Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20181112 |